ArticleInternational journal of dermatology2026
Decoding Genetic Disease Through the Skin: Lessons From the UDN.
Article in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expanded Clinical Spectrum of Autosomal-Dominant STT3A-CDG.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundSkin findings are often among the earliest signs of genetic disease but remain underused in diagnostic evaluation, especially in complex or multisystem cases.
objectivesWe aimed to examine how dermatologic features contribute to genetic diagnoses in patients evaluated through the Undiagnosed Diseases Network (UDN).
methodsWe conducted a retrospective study of 2849 individuals referred to the UDN from 2015 to 2025. All underwent comprehensive clinical evaluation and genome-wide sequencing. Skin findings were identified using Human Phenotype Ontology (HPO) terms and assessed for their association with diagnostic yield and time to diagnosis using odds ratios, Fisher's exact tests, and t-tests.
resultsA confirmed genetic diagnosis was made in 911 individuals. Eighteen were diagnosed with a primary genodermatosis, including four with somatic mosaicism, three of whom required biopsy of affected skin for confirmation. Skin-related HPO terms were present in about one-third of both diagnosed and undiagnosed individuals. While general skin findings were not predictive, specific features were strongly associated with diagnosis. These included café au lait macules (odds ratio 6.75), decreased palmar creases (odds ratio 5.61), and prominent fingertip pads (odds ratio 2.36). In contrast, bruising susceptibility was associated with a lower likelihood of diagnosis. Diagnostic delay was shorter for primary dermatologic disorders, though not statistically significant.
conclusionsSkin features, even subtle ones, can provide powerful diagnostic clues in rare diseases. Integrating focused dermatologic evaluation and tissue-specific testing, particularly for suspected mosaicism, can enhance diagnostic accuracy and shorten the path to answers for patients and families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.